Health care stocks were higher in Friday afternoon trading, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each adding 0.5%.
The iShares Biotechnology ETF (IBB) was up 0.2%.
In corporate news, Silo Pharma (SILO) shares jumped more than 11%. The company said Friday it has agreed to collaborate with Kymanox to design and develop a subcutaneous insertion device for SP-26, its ketamine-loaded implant for the potential treatment of fibromyalgia and chronic pain.
Grifols (GRFS) shares sank past 13%. The company is in talks with banks to extend a $1 billion revolving credit facility and refinance 370 million euros ($390.3 million) in bonds due 2025, Bloomberg reported Thursday, citing an interview with Chief Executive Nacho Abia.
Applied Therapeutics (APLT) shares plunged 75%. The company said late Wednesday that the US Food and Drug Administration issued a complete response letter indicating the health regulator's decision not to approve a new drug application for govorestat to treat classic galactosemia.
Evotec (EVO) shares dropped 3.1% after the company said Friday that Craig Johnstone will step down as chief operating officer and leave the company, effective Dec. 31.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。